Difficulty: Medium
Average Score: 75%
Practice
The client has developed neutropenia from a medication. What medication might this be?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Captopril. Captopril is an angiotensin-converting enzyme (ACE) inhibitor commonly associated with adverse effects such as neutropenia, a condition characterized by a low count of neutrophils, a type of white blood cell crucial for fighting infections. ACE inhibitors can sometimes lead to bone marrow suppression, resulting in neutropenia.
Metoprolol (A) is a beta-blocker used to treat hypertension and other cardiovascular conditions. It is not typically associated with neutropenia. Lisinopril (C) is another ACE inhibitor like captopril, but it is less likely to cause neutropenia compared to captopril. Guanfecine (D) is a centrally acting alpha-2 adrenergic agonist used for hypertension and is not known to cause neutropenia.
Educationally, understanding the adverse effects of cardiovascular drugs is crucial for healthcare professionals to make informed decisions when prescribing medications. Recognizing potential adverse effects allows for timely intervention and management to ensure patient safety and well-being. This knowledge underscores the importance of thorough medication assessments and monitoring for adverse reactions in clinical practice.
Metoprolol (A) is a beta-blocker used to treat hypertension and other cardiovascular conditions. It is not typically associated with neutropenia. Lisinopril (C) is another ACE inhibitor like captopril, but it is less likely to cause neutropenia compared to captopril. Guanfecine (D) is a centrally acting alpha-2 adrenergic agonist used for hypertension and is not known to cause neutropenia.
Educationally, understanding the adverse effects of cardiovascular drugs is crucial for healthcare professionals to make informed decisions when prescribing medications. Recognizing potential adverse effects allows for timely intervention and management to ensure patient safety and well-being. This knowledge underscores the importance of thorough medication assessments and monitoring for adverse reactions in clinical practice.